BR0115076A - Formulação inalável de uma solução contendo um sal de tiotrópio - Google Patents

Formulação inalável de uma solução contendo um sal de tiotrópio

Info

Publication number
BR0115076A
BR0115076A BR0115076-6A BR0115076A BR0115076A BR 0115076 A BR0115076 A BR 0115076A BR 0115076 A BR0115076 A BR 0115076A BR 0115076 A BR0115076 A BR 0115076A
Authority
BR
Brazil
Prior art keywords
solution containing
inhalable formulation
tiotropium salt
inhalable
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
BR0115076-6A
Other languages
English (en)
Other versions
BRPI0115076B1 (pt
BRPI0115076B8 (pt
Inventor
Barbara Niklaus-Humke
Christel Schmelzer
Petra Barth
Karin Drechsel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of BR0115076A publication Critical patent/BR0115076A/pt
Publication of BRPI0115076B1 publication Critical patent/BRPI0115076B1/pt
Publication of BRPI0115076B8 publication Critical patent/BRPI0115076B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"FORMULAçãO INALáVEL DE UMA SOLUçãO CONTENDO UM SAL DE TIOTRóPIO". A presente invenção refere-se a uma formulação inalável de brometo de tiotrópio ou monoidrato de brometo de tiotrópio livre de propelentes dissolvida em água ou em uma mistura de água e etanol e aos aerossóis inaláveis livres de propelentes resultantes da mesma.
BRPI0115076A 2000-10-31 2001-10-24 preparação farmacêutica, sua aplicação farmacêutica, bem como processo para preparação da mesma BRPI0115076B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10054036 2000-10-31
PCT/EP2001/012292 WO2002036104A2 (de) 2000-10-31 2001-10-24 Inhalative lösungsformulierung mit einem tiotropiumsalz

Publications (3)

Publication Number Publication Date
BR0115076A true BR0115076A (pt) 2003-07-29
BRPI0115076B1 BRPI0115076B1 (pt) 2016-07-26
BRPI0115076B8 BRPI0115076B8 (pt) 2021-05-25

Family

ID=7661723

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0115076A BRPI0115076B8 (pt) 2000-10-31 2001-10-24 preparação farmacêutica, sua aplicação farmacêutica, bem como processo para preparação da mesma

Country Status (39)

Country Link
EP (2) EP1333819B1 (pt)
JP (1) JP4344135B2 (pt)
KR (1) KR100853107B1 (pt)
CN (2) CN100396285C (pt)
AR (1) AR038764A1 (pt)
AT (1) ATE373473T1 (pt)
AU (2) AU2002221738B2 (pt)
BG (1) BG66315B1 (pt)
BR (1) BRPI0115076B8 (pt)
CA (1) CA2426074C (pt)
CY (1) CY1107825T1 (pt)
CZ (1) CZ300794B6 (pt)
DE (2) DE50113037D1 (pt)
DK (1) DK1333819T3 (pt)
EA (1) EA007604B1 (pt)
EC (1) ECSP034541A (pt)
EE (1) EE05314B1 (pt)
ES (1) ES2294045T3 (pt)
HK (1) HK1060524A1 (pt)
HR (1) HRP20030338B1 (pt)
HU (1) HU229411B1 (pt)
IL (2) IL155538A0 (pt)
ME (1) ME00244B (pt)
MX (1) MXPA03003742A (pt)
MY (1) MY138940A (pt)
NO (1) NO332519B1 (pt)
NZ (1) NZ526023A (pt)
PE (1) PE20030092A1 (pt)
PL (1) PL203316B1 (pt)
PT (1) PT1333819E (pt)
RS (1) RS50859B (pt)
SA (1) SA01220482B1 (pt)
SI (1) SI1333819T1 (pt)
SK (1) SK286027B6 (pt)
TW (1) TWI293885B (pt)
UA (1) UA78690C2 (pt)
UY (1) UY26989A1 (pt)
WO (1) WO2002036104A2 (pt)
ZA (1) ZA200302922B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
CN1292748C (zh) * 2003-03-05 2007-01-03 南昌弘益科技有限公司 噻托溴铵吸入粉雾剂及其制备工艺
PT1682541E (pt) * 2003-11-03 2010-04-14 Boehringer Ingelheim Int Processo para a preparação de sais de tiotrópio
PL2083007T3 (pl) * 2003-11-03 2013-09-30 Boehringer Ingelheim Int Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
EP1881980B1 (en) 2005-05-02 2012-08-22 Boehringer Ingelheim International GmbH Novel crystalline forms of tiotropium bromide
EP2044967A1 (de) * 2007-10-01 2009-04-08 Boehringer Ingelheim Pharma GmbH & Co. KG Zerstäuber
CN104306361A (zh) * 2014-09-24 2015-01-28 万特制药(海南)有限公司 一种含噻托溴铵的吸入性溶液
CN111374963A (zh) * 2018-12-31 2020-07-07 天津药业研究院有限公司 一种用于吸入的噻托铵溶液剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

Also Published As

Publication number Publication date
KR20030060926A (ko) 2003-07-16
ZA200302922B (en) 2004-04-22
EE05314B1 (et) 2010-08-16
ME00244B (me) 2011-05-10
EP1333819A2 (de) 2003-08-13
HUP0301378A3 (en) 2005-12-28
UA78690C2 (uk) 2007-04-25
AU2173802A (en) 2002-05-15
HRP20030338B1 (en) 2011-09-30
HUP0301378A2 (hu) 2003-10-28
BRPI0115076B1 (pt) 2016-07-26
YU33003A (sh) 2006-05-25
HRP20030338A2 (en) 2005-04-30
DE10152521A1 (de) 2002-07-11
SA01220482B1 (ar) 2007-07-31
ES2294045T3 (es) 2008-04-01
SK286027B6 (sk) 2008-01-07
ECSP034541A (es) 2003-05-26
DE50113037D1 (de) 2007-10-31
WO2002036104A2 (de) 2002-05-10
SI1333819T1 (sl) 2007-12-31
WO2002036104A3 (de) 2002-08-01
PL203316B1 (pl) 2009-09-30
PE20030092A1 (es) 2003-03-24
KR100853107B1 (ko) 2008-08-21
UY26989A1 (es) 2002-06-20
NZ526023A (en) 2005-05-27
MEP40408A (en) 2011-02-10
EP1837021A3 (de) 2008-03-19
CN100396285C (zh) 2008-06-25
CA2426074C (en) 2008-12-23
IL155538A0 (en) 2003-11-23
HU229411B1 (en) 2013-12-30
RS50859B (sr) 2010-08-31
NO20031911L (no) 2003-04-29
CZ300794B6 (cs) 2009-08-12
MY138940A (en) 2009-08-28
CY1107825T1 (el) 2013-06-19
SK5272003A3 (en) 2003-10-07
TWI293885B (en) 2008-03-01
BG107727A (bg) 2004-11-30
ATE373473T1 (de) 2007-10-15
CZ20031486A3 (cs) 2003-08-13
HK1060524A1 (en) 2004-08-13
NO332519B1 (no) 2012-10-08
JP4344135B2 (ja) 2009-10-14
EA007604B1 (ru) 2006-12-29
EE200300203A (et) 2003-10-15
MXPA03003742A (es) 2004-10-15
CN101292964A (zh) 2008-10-29
EP1333819B1 (de) 2007-09-19
IL155538A (en) 2008-11-26
EP1837021A2 (de) 2007-09-26
JP2004512357A (ja) 2004-04-22
PT1333819E (pt) 2007-10-29
DK1333819T3 (da) 2007-12-03
AR038764A1 (es) 2005-01-26
BRPI0115076B8 (pt) 2021-05-25
AU2002221738B2 (en) 2007-01-11
BG66315B1 (bg) 2013-04-30
PL360405A1 (en) 2004-09-06
NO20031911D0 (no) 2003-04-29
CA2426074A1 (en) 2002-05-10
CN1473038A (zh) 2004-02-04
EA200300482A1 (ru) 2003-12-25

Similar Documents

Publication Publication Date Title
PE20010400A1 (es) Formulacion de sal comun y moxifloxacina
BR0114253A (pt) Antagonistas de receptor de glutamato metabotrópico
BR0015568A (pt) Composto de pirazolona substituìdo com heterocìclico, composição farmacêutica contendo o mesmo e seu uso
BRPI0518231A2 (pt) derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica
ES2128735T3 (es) Composiciones farmaceuticas que comprenden un antagonista de opiaceos y de sales de calcio y su uso para el tratamiento de patologias en las que intervienen las endorfinas.
DE60232017D1 (de) Flüssige zusammensetzung aus faktor vii polypeptiden
DE69912279D1 (de) 5-ht1f agonisten
BR0212586A (pt) Composição, uso de uma combinação de ipratrópio ou um sal deste e de xilometazolina ou um sal desta, e, métodos para o tratamento de uma condição selecionada ao grupo que consiste de sintomas associados com o resfriado comum e sintomas associaods com a rinite e para estabilizar uma solução aquosa de ipratrópio ou um sal deste e xilometazolina ou um sal desta
BR0110955A (pt) Derivados de tropano úteis para a terapia
BR0316948A (pt) Composto, formulação farmacêutica, e, uso de um composto
BR0012082A (pt) Formulação farmacêutica para administração compreendendo morfina e seu uso
BR0115076A (pt) Formulação inalável de uma solução contendo um sal de tiotrópio
BR0115016A (pt) Formulação de solução inalativa com um sal de tiotrópio
AR035889A1 (es) Citrato de 5,7,14-triazatetraciclo[10.3.1.02,11.04,9]hexadeca-2(11),3,5,7,9- pentaeno y composiciones farmaceuticas que la contienen y su uso para la elaboracion de medicamentos
NO308607B1 (no) Kjemisk forbindelse, et farmasøytisk preparat inneholdende denne, samt anvendelse av forbindelsen til fremstilling av en blodplateaggregeringsinhibiotor og fremstilling av et farmasøytisk preparat til behandling eller forebygging av trombotiske
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
NO972377L (no) Indolderivater og medisinsk anvendelse derav
GT199900171A (es) Concentrado oral de sertralina.
BR0008479A (pt) Agonistas de 5-ht 1f
BRPI0416411A (pt) uso de deoxipeganina
DE69312322D1 (de) Cephem verbindungen mit antimicrobizide eigenschaften
TH52368A (th) สารออกฤทธิ์ทางเภสัชกรรมชนิดใหม่
ES2037825T3 (es) Uso farmaceutico de tioeteres aromaticos.
TH34148A (th) สารต้านเชื้อราเอโซลที่มีเอสเตอร์ของกรดอะมิโน
BR9806902A (pt) Composto, formulação farmacêutica, uso de um composto, e processos para produzir um composto e uma formulação farmacêutica.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/07/2016, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/10/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 24/10/2021